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Abstract
In the present study, we evaluated rapid real-time PCR assays for ply, Spn9802, and lytA applied to plasma samples for the detection of
Streptococcus pneumoniae in patients with community-acquired pneumonia (CAP). In a prospective study of CAP aetiology, an EDTA
plasma sample was collected together with blood culture in 92 adult CAP patients and 91 adult controls. Among the 92 CAP patients,
lytA PCR was positive in eight (9%), Spn9802 PCR was positive in 11 (12%) and ply PCR was positive in 19 (21%) cases. Of 91 controls,
the ply PCR was positive in eight cases (9%), but no positive cases were noted by Spn9802 or lytA PCRs. Ten CAP patients had pneu-
mococcal bacteraemia. Compared to blood culture, PCR for lytA, Spn9802 and ply had sensitivities of 70% (7/10), 60% (6/10) and 70%
(7/10), and speciﬁcities of 96% (79/82), 94% (77/82) and 85% (70/82) respectively. With blood culture and/or culture of representative
sputum, and/or urinary antigen detection, S. pneumoniae was identiﬁed in 31 CAP patients. Compared to these tests in combination,
PCR for lytA, Spn9802 and ply showed sensitivities of 26% (8/31), 32% (10/31) and 42% (13/31), and speciﬁcities of 100% (61/61), 98%
(60/61) and 90% (55/61) respectively. We conclude that Spn9802 and lytA PCRs may be useful for the rapid detection of bacteraemic
pneumococcal pneumonia, whereas ply PCR is not speciﬁc enough for routine use and blood PCR with small plasma volumes is not
useful for the detection of nonbacteraemic pneumococcal pneumonia.
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Introduction
Streptococcus pneumoniae is the chief cause of community-
acquired pneumonia (CAP) [1]. The diagnosis of pneumococ-
cal pneumonia is hindered by the lack of a highly sensitive
and speciﬁc ‘gold standard’ method. Culture of sputum and
nasopharyngeal secretions is controversial as a result of
respiratory tract carriage of pneumococci. Bronchoalveolar
lavage or transthoracic needle aspiration are considered to
be reliable but they are invasive and cannot be performed
routinely. Identiﬁcation of the bacterium in blood culture
provides a deﬁnite diagnosis and can serve as an indicator of
disease severity. However, the positivity rate of blood cul-
tures rarely exceeds 10% in CAP [2], and can be below 1% if
blood samples are obtained during antimicrobial treatment
[3].
The use of PCR protocols to detect multiple bacteria in
blood samples is increasing in clinical practice. Commercial
PCR procedures applied to blood samples, such as SeptiFast
(Roche Diagnostics, Mannheim, Germany) and SepsiTest
(Molzym, Bremen, Germany) use conserved PCR targets such
as the internal transcribed spacer region and 16S rRNA, for
genes that are common to all bacteria. This is a promising
strategy for pathogens such as Staphylococcus aureus and
Gram-negative enteric bacilli. However, it is difﬁcult for PCR
against common bacterial genes to distinguish between
S. pneumoniae and alpha-haemolytic streptococci because they
are closely related [4,5]. Another target, the DNA fragment
Spn9802, has an unknown function, but has been described as
a speciﬁc target for S. pneumoniae [6]. In the present study,
we aimed to evaluate the performance of PCR of three differ-
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ent gene targets of S. pneumoniae (pneumolysin, ply; autolysin,
lytA; and the DNA fragment Spn9802), aiming to identify a
PCR assay that could be used to detect S. pneumoniae DNA
in blood samples from acutely febrile patients.
Materials and Methods
Patients
At the 35-bed Department of Infectious Diseases, O¨rebro
University Hospital, O¨rebro, Sweden, patients with CAP
were enrolled in a prospective study running from November
1999 until April 2002 [7]. The criteria for CAP were: acute
illness, radiological signs of pulmonary consolidation, at least
two of ﬁve signs and symptoms of pneumonia (fever >38C,
dyspnea, cough, pleuritic chest pain, and abnormal lung aus-
cultation), but no hospitalization during the preceding month.
From 235 enrolled patients (median age 71 years) who ful-
ﬁlled the CAP criteria, an EDTA plasma sample was available
in 92 cases where blood culture was also performed. There
was no systematic bias selection of patients who provided
plasma. These patients were included in the present study.
The 92 patients had a median age of 70 (range 19–93) years;
44 (48%) were females, and 19 (21%) were current smokers.
A comorbid illness was noted in 41 patients (45%), including
14 with chronic obstructive pulmonary disease. A Pneumonia
Severity Index Risk Class of IV-V was noted in 32 cases (35%),
and a CURB-65 score of 3–5 was noted in 17 (18%). Eight
patients (9%) were treated in the intensive care unit, and two
patients (2%) died within 30 days of hospitalization.
During the study period, adult control patients hospitalized
for skin infection, urinary tract infection, arthritis/spondylitis,
or planned orthopaedic/urological surgery, but without respi-
ratory symptoms on admission, were enrolled [7].
From 113 enrolled controls, EDTA plasma samples were
available from 91 (median age 67 years, range 33–87 years),
and these 91 were used in the present study.
Microbiological analysis
Two blood cultures, with two bottles in each, were collected
from all patients and controls. Blood culture I was collected
at the emergency department and blood culture II was col-
lected on the ward. A Bactec nonradiometric system, 9240
(Becton Dickinson, Sparks, MD, USA), was used for blood
culturing. The pneumococcal strains isolated from blood
were serotyped by using type-speciﬁc pneumococcal rabbit
antisera (Statens Serum Institut, Copenhagen, Denmark).
Sputum samples were obtained from the CAP patients. Sam-
ples with more than ﬁve leukocytes per epithelial cell were
deemed representative and were subjected to culture. Naso-
pharyngeal aspirates where obtained from both CAP patients
and controls. These aspirates (10 lL) and a diluted aliquot of
sputum, giving a detection level of 2 · 105 colony-forming
units/mL sputum, were cultured on blood agar with gentian
violet. The plates were incubated for 24–48 h at 37C in 5%
carbon dioxide, and bacterial species were identiﬁed by stan-
dard microbiological methods.
Urinary antigen test
The Binax NOW immunochromatographic test for S. pneu-
moniae (Binax, Portland, ME, USA) was performed on non-
concentrated urine from the CAP patients and controls.
DNA extraction
Together with blood culture II, an EDTA sample was col-
lected and centrifuged to obtain plasma. After storage at
)70C, the plasma samples (400 lL) were subjected to
DNA extraction with the automatic NucliSens easyMAG
instrument (bioMe´rieux, Marcy l’Etoile, France). The sample
was eluted in 25 lL of elution buffer. Puriﬁed DNA was then
run in a duplex real-time PCR for the ply gene and the
Spn9802 fragment and a real-time PCR for the lytA gene of
S. pneumoniae.
Spn9802 PCR and ply PCR
Spn9802 has been shown as a speciﬁc target for S. pneumo-
niae [6] and we have previously developed a method that
also enables detection of S. pseudopneumoniae [8]. This real-
time PCR was combined with ply real-time PCR [9] and run
as a duplex real-time PCR. The primers and probes are
shown in Table 1. This duplex PCR was run under the same
thermal conditions as previously described for the ply PCR
[10]. As a control for ampliﬁcation of the speciﬁc target and
as a standard for quantiﬁcation, DNA preparations of 500,
2000 and 10 000 bacterial genomes per PCR reaction (refer-
ence strain S. pneumoniae CCUG 28588T) were used. A well
with a negative control (water) was also used for each reac-
tion mix.
lytA PCR
In the lytA real-time PCR, the gene was ampliﬁed using the
LightCycler 2.0 system using LightCycler Software, version
4.1 (Roche Diagnostics) with probe detection (Table 1). The
optimized real-time PCR ampliﬁcations were performed in a
20-lL reaction volume, containing 0.7 and 0.5 lM of forward
and reverse primers [11] (Scandinavian Gene Synthesis,
Ko¨ping, Sweden), respectively, 0.3 and 0.2 lM of the probes
P1 and P2 (TIB MOLBIOL Syntheselabor, Berlin, Germany),
respectively, 3.5 mM MgCl2, and 2 lL of LightCycler
Faststart Reaction Mix Hybridization Probes (Roche Diagnos-
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tics). The assay used 5 lL of target DNA. The PCR program
includes an enzyme activation step at 95C for 10 min,
followed by 45 cycles at 95C for 5 s, 60C for 20 s (single
measurement of ﬂuorescence) and 72C for 8 s. As a posi-
tive control for the target speciﬁc PCRs, DNA preparations
of 100–1000 bacterial genomes per PCR (reference strain
S. pneumoniae CCUG 36696) were used as well as a negative
control for each reaction mix.
Ethics
The study was approved by the Ethics Committee of O¨rebro
County Council. All participants provided their informed
consent.
Results
Conventional diagnostic methods
Among the 92 CAP patients, S. pneumoniae was identiﬁed by
blood culture in ten patients (11%), by urinary antigen test in
24/86 (28%) patients tested, by sputum culture in 13/48
(27%) of patients with representative sputum sample avail-
able, and by culturing nasopharyngeal aspirate in 28/84 (33%)
patients tested. S. pneumoniae was detected by urinary anti-
gen test and/or sputum culture in 31 cases, including the ten
patients with pneumococcal bacteraemia. Thus, there were
ten patients with bacteraemic pneumococcal pneumonia and
21 with nonbacteraemic pneumococcal pneumonia. The
remaining 61 CAP were deemed to have nonpneumococcal
pneumonia.
In the control group, S. pneumoniae was identiﬁed by uri-
nary antigen test in two of 89 (2%) of patients tested and by
nasopharyngeal aspirate culture in four of 91 (4%) patients
tested.
Real-time PCR for ply, Spn9802, and lytA
Table 2 shows the detection rates of PCR for ply, Spn9802,
and lytA in the CAP patients and controls. lytA and Spn9802
were detected predominantly in cases with bacteraemic
pneumococcal pneumonia, whereas ply was also detected in
several patients with nonpneumococcal pneumonia and
among the controls.
Table 3 shows the results of the individual CAP patients
with positive blood culture and/or positive PCR. Among the
ten patients with bacteraemic pneumococcal pneumonia, six
were positive by all three PCR methods, whereas two were
negative with all three PCR methods. No PCR inhibition was
seen in these latter two samples when retested with spiked
pneumococcal DNA. To study the presence of the three
genes in the bacteraemic isolates, we tested the ten S. pneu-
TABLE 1. Sequences of oligonu-
cleotide primers and probes for
detection of Streptococcus pneumo-
niae
Sequences (5¢ to 3¢)a
Positions in
target geneb
Spn9802 F 5¢-AGTCGTTCCAAGGTAACAAGTCT-3¢ 3370 to 3392
Spn9802 R 5¢-ACCAACTCGACCACCTCTTT-3¢ 3525 to 3506
Spn9802 FAM 5¢-FAM-aTcAGaTTgCTgATaAAaCgA-BHQ1-¢3
lytA F 5¢-CAGCGGTTGAACTGATTGA-¢3 251 to 269
lytA R 5¢-TGGTTGGTTATTCGTGCAA-¢3 423 to 405
lytA P1 5¢-GAAAACGCTTGATACAGGGAGTT-FL-¢3
lytA P2 5¢-LCRed640-AGCTGGAATTAAAACGCACGAG-PH-¢3
ply F 5¢-TGCAGAGCGTCCTTTGGTCTAT-¢3 894 to 915
ply R 5¢-CTCTTACTCGTGGTTTCCAACTTG-¢3 974 to 950
ply Cy5 5¢-Cy5-TGGCGCCCATAAGCAACACTCGAA-BHQ1-¢3
aPositions with lower case letters indicate a locked nucleic acid [28].
bAccession numbers: Spn9802; AE008434, lytA; NC_003098 and ply; X52474.
TABLE 2. Detection rates by PCR
with three different gene targets of
Streptococcus pneumoniae applied
to EDTA blood samples from 92
pneumonia patients and 91 adult
controls without respiratory symp-
toms
PCR gene
target
Pneumonia patients
Controls
(n = 91)
Number
positive (%)
Bacteraemic
pneumococcal
pneumonia
(n = 10)
Number
positive (%)
Nonbacteraemic
pneumococcal
pneumoniaa
(n = 21)
Number
positive (%)
Nonpneumococcal
pneumoniab
(n = 61)
Number
positive (%)
ply 7 (70) 6 (29) 6 (10) 8 (9)
Spn9802 6 (60) 4 (19) 1 (2) 0
lytA 7 (70) 1 (5) 0 0
aBlood culture negative but S. pneumoniae detected by culture of representative sputum or by urinary antigen test.
bS. pneumoniae not detected by blood culture, culture of representative sputum, or urinary antigen test.
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moniae isolates with the PCR protocols. All ten isolates were
positive for ply, Spn9802 and lytA (details not shown).
Among the bacteraemic cases, the DNA copy number per
mL was similar for Spn9802 and ply, but was lower for lytA
(Table 3). Spn9802 PCR was positive at low copy numbers
(14–152 copies/reaction; 200–2000 copies/mL) in ﬁve
patients with negative blood cultures. In four of these cases,
S. pneumoniae was also detected by urinary antigen test or
sputum culture. All samples positive by ply PCR alone had
low copy numbers (<103 copies/mL).
In the control group, no subject was positive with lytA
PCR or Spn9802 PCR, but eight subjects were positive with
ply PCR at concentrations of 6 · 101 to 2 · 103 DNA cop-
ies/mL. In two of the ply PCR positive controls, other tests
were positive for S. pneumoniae (urinary antigen and culture
of nasopharyngeal aspirate (n = 1) and culture of nasopha-
ryngeal aspirate (n = 1)). In the controls with all three PCR
reactions negative, S. pneumoniae urinary antigen test was
positive in one control and culture of nasopharyngeal aspi-
rate was positive in two controls.
The diagnostic performance of the three PCR assays in
the CAP cases is shown in Table 4. The sensitivities were
low (26–42%) for the diagnosis of pneumococcal pneumonia,
although the speciﬁcities were high for Spn9802 (98%) and
lytA (100%). The sensitivities were higher (60–70%) for the
diagnosis of bacteraemic pneumococcal pneumonia, and
speciﬁcities remained high for Spn9802 (94%) and lytA (99%).
Consequently, Spn9802 and lytA had high positive predictive
TABLE 3. Community-acquired pneumonia patients with positive blood culture and/or positive PCR for Streptococcus pneumo-
niae applied to blood samples
Sex, age
Blood culture
result and
serotype
lytA PCR
(copies/mL)
Spn9802 PCR
(copies/mL)
ply PCR
(copies/mL)
S. pneumoniae
urinary
antigen test
Sputum
culture for
S. pneumoniae
Culture of
nasopharyngeal
aspirate for
S. pneumoniae
F, 83 S. pneumoniae 19F 9 · 108 1 · 1010 4 · 109 + ND ND
F, 79 S. pneumoniae 9V 2 · 108 3 · 109 1 · 109 + ND ND
M, 91 S. pneumoniae 23F 6 · 102 2 · 104 2 · 104 + ND +
F, 89 S. pneumoniae 7F 2 · 102 2 · 104 1 · 104 + ND +
M, 54 S. pneumoniae 3 3 · 102 5 · 103 8 · 103 + + +
F, 74 S. pneumoniae 7 F 2 · 102 1 · 103 1 · 103 + ND ND
F, 84 S. pneumoniae 23F 8 · 101 0 0 + + +
F, 57 S. pneumoniae 7F 0 0 3 · 102 + ND +
M, 31 S. pneumoniae 7F 0 0 0 + ND +
F, 85 S. pneumoniae 23F 0 0 0 + ND )
M, 23 ) 1 · 102 6 · 103 1 · 104 + ) +
F, 78 ) 0 2 · 103 6 · 101 + ND ND
M, 58 ) 0 6 · 102 2 · 102 + ) +
M, 74 ) 0 2 · 102 6 · 102 ) + )
M, 31 ) 0 4 · 102 1 · 102 ) ) +
M, 87 ) 0 0 9 · 102 + ND +
F, 77 ) 0 0 3 · 102 + + +
M, 46 ) 0 0 6 · 102 ND ND )
F, 69 ) 0 0 5 · 102 ) ND )
M, 51 ) 0 0 3 · 102 ) ) )
M, 75 ) 0 0 2 · 102 ) ) )
F, 32 ) 0 0 2 · 102 ) ND )
ND, not done; ‘)’, negative.
TABLE 4. Performance of PCR for
three different gene targets of
Streptococcus pneumoniae applied
to EDTA blood samples from 92
pneumonia patients
Reference group
PCR gene
target Sensitivitya Speciﬁcityb
Positive
predictive
valuec
Negative
predictive
valued
Pneumococcal pneumoniae ply 42 (13/31) 90 (55/61) 68 (13/19) 75 (55/73)
Spn9802 32 (10/31) 98 (60/61) 91 (10/11) 74 (60/81)
lytA 26 (8/31) 100 (61/61) 100 (8/8) 73 (61/84)
Bacteraemic pneumococcal
pneumonia
ply 70 (7/10) 85 (70/82) 37 (7/19) 96 (70/73)
Spn9802 60 (6/10) 94 (77/82) 55 (6/11) 95 (77/81)
lytA 70 (7/10) 99 (81/82) 88 (7/8) 96 (81/84)
aReported as percentage (number with positive PCR/number with the deﬁned pneumonia diagnosis).
bReported as percentage (number with negative PCR/number without the deﬁned pneumonia diagnosis).
cReported as percentage (number with the deﬁned pneumonia diagnosis/number with positive PCR).
dReported as percentage (number without the deﬁned pneumonia diagnosis/number with negative PCR).
eS. pneumoniae detected by blood culture, culture of representative sputum, or urinary antigen test.
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values for pneumococcal pneumonia and high negative pre-
dictive values for bacteraemic pneumococcal pneumonia.
Test results in patients with prior antibiotic treatment
Antibiotics were administered prior to blood culturing in 27
cases. In these cases, the positive results for S. pneumoniae
noted were: blood culture, urinary antigen test and the three
PCR analyses (n = 1), urinary antigen test and the three PCR
analyses (n = 1), urinary antigen test, Spn9802 PCR and ply
PCR (n = 1), sputum culture alone (n = 1), Spn9802 PCR
and ply PCR (n = 1), and ply PCR alone (n = 3). Thus,
Spn9802 and/or lytA PCR were positive in three of 26 cases
with prior antibiotics and negative blood culture.
Discussion
The present study tested the performance of three real-time
PCR assays for the detection of S. pneumoniae in plasma sam-
ples from patients with CAP. In general, the sensitivity of the
PCR assays was low for the detection of both pneumococcal
pneumonia (26–42%) and pneumococcal bacteraemia (60–
70%); similar ﬁgures have been reported in previous studies
[11–13]. This is likely to have been a result of the sample
volume used in the DNA extraction. We used 400 lL of
plasma, and 5 lL (corresponding to 80 lL of the original
plasma) of the puriﬁed DNA for PCR. The use of such a
small volume limits the detection capacity, especially in cases
of low-grade bacteraemia. In comparison, the blood volume
in the four blood culture bottles was approximately 40 mL
(4 · 10 mL), corresponding to approximately 20–25 mL of
plasma. The problem with small sample volumes can be
solved by processing a larger volume of blood for PCR, com-
prising a methodological challenge that has been elaborated
in a commercial test system. However, no advantage of PCR
detection of bacteria in blood has been reported, even with
collection volumes was between 1.5 and 10 mL [14,15].
Methods for selective isolation of bacterial DNA from blood
have also been reported [16], but it not yet clear what bene-
ﬁt such techniques provide.
Several studies have used ply PCR to the detect S. pneumo-
niae DNA in blood samples, with sensitivities in the range 35–
100% compared to blood culture [12,17–20]. However, we
[10] and others [21] have shown that ply PCR is unspeciﬁc for
the detection of S. pneumoniae in respiratory secretions. In
the present study, the ply gene PCR presumably caused false
positivity also in blood, which is a site that is assumed to be
‘sterile’. Healthy adults with false-positive ply PCR with blood
samples have been identiﬁed previously [17,19,22]. The cause
is not known, although laboratory contamination with pneu-
mococcal DNA was suspected [19]. The present study, with
discrepant results between those obtained for ply PCR and
the other two PCR assays in the control group, demonstrates
that laboratory contamination with pneumococcal DNA is
not likely to have been a signiﬁcant cause of false-positive ply
PCR results. It has been speculated that such false-positive
results can also be caused by alpha-haemolytic streptococci
[22]. These streptococci from normal oral ﬂora can enter the
bloodstream even after tooth brushing [23,24] and some spe-
cies, such as Streptococcus mitis and Streptococcus oralis, have
been reported to harbour the ply gene [25,26]. In the present
study, however, all patients and controls with ply PCR positiv-
ity had blood cultures negative for alpha-haemolytic strepto-
cocci. Furthermore, in a recent study by our group [10], ply
PCR positivity in bronchoalveolar lavage ﬂuid was not corre-
lated with culture positivity for alpha-haemolytic streptococci.
Perhaps the detected ply DNA in plasma samples and respira-
tory secretions from patients with negative cultures origi-
nated from degraded bacteria introduced from the oral ﬂora.
In healthy children, nasopharyngeal carriage of S. pneumo-
niae has been shown to give positive ply PCR results in blood
samples [27], as well as a positive S. pneumoniae urinary anti-
gen test [28]. To our knowledge, PCR for lytA and Spn9802
have not been tested on blood samples from paediatric
patients and the impact of S. pneumoniae carriage on these
tests has only rarely been tested on blood samples from
adults. Among four adult controls with S. pneumoniae car-
riage in the present study, one had a positive urinary antigen
test, two were positive with ply PCR and none were positive
with lytA PCR or Spn9802 PCR .
As noted, the concentration of ply DNA was low in the
patients with no other test positive for S. pneumoniae
(Table 3) and in the controls. However, because of its low
speciﬁcity, we consider that ply should not be used as gene
target in PCR assays for S. pneumoniae.
Both lytA and Spn9802 have been found speciﬁc for
S. pneumoniae [8,11]. The present study clearly shows that
lytA PCR and Spn9802 PCR applied to plasma samples are
speciﬁc for the detection of S. pneumoniae.
The differences in DNA copy numbers between lytA PCR
and Spn9802 PCR (Table 3) are most likely to be a result of
inter-method variability, showing that quantitative data
should be interpreted with caution. However, the high posi-
tive predictive values of lytA PCR and Spn9802 PCR (Table 4)
make them promising for use in clinical practice, alone or in
a multiplex PCR assay for different bacteria. This could facili-
tate the rapid (<2.5 h) detection of pneumococcal infection
in febrile patients. Thus, a patient with positive Spn9802 PCR
or lytA PCR could be given suitable treatment at an early
stage of the disease.
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Detection of pneumococcal antigen in blood samples has
been associated with disease severity in CAP [29]. The main
reason for this is a high correlation with bacteraemia and
the requirement for a large number of S. pneumoniae to give
rise to detectable levels of polysaccharides in blood. Bactera-
emia has been associated with mortality in CAP [30]. To our
knowledge, there have been no studies that correlate disease
severity with PCR for S. pneumoniae in blood samples. The
present study was not designed to investigate this issue;
however, the results obtained suggest that plasma PCR may
provide prognostic information. A positive result of lytA PCR
or Spn9802 PCR can be used for rapid diagnosis of bacterae-
mic pneumococcal pneumonia, which is a potentially severe
condition [30].
A limitation of the present study is that there were few
cases of bacteraemic pneumococcal pneumonia, although suf-
ﬁcient cases to demonstrate a performance of blood PCR
similar to that in other studies of this condition [11,13].
There are few reports of the performance of blood-PCR to
detect nonbacteraemic pneumococcal pneumonia. The pres-
ent study demonstrates that blood PCR with small plasma
volumes is not useful for the detection of nonbacteraemic
pneumococcal pneumonia.
Culture remains the basic method for detection of pneu-
mococci in routine clinical microbiology; it is cheap and
enables antibiotic resistance determination. Real-time PCR
assays based on speciﬁc targets such as lytA and Spn9802 are
useful when a rapid analysis is required or when antibiotic
treatment has been started prior to sampling.
The use of an unspeciﬁc PCR target such as ply should
only be considered when there is a research interest with
respect to ﬁnding strains of S. mitis or S. oralis that are clo-
sely related to S. pneumoniae.
We conclude that the detection of Spn9802 and lytA PCRs
in plasma is useful for the rapid detection of bacteraemic
pneumococcal pneumonia, whereas ply is not speciﬁc enough
for this organism in blood samples.
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